Study identifies proteins involved in the effectiveness of immunotherapy against blood cancer

A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways involved in the efficacy of immunotherapy based on CAR-T cells (lymphocytes modified in the laboratory to fight cancer).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup